Exercise during chemotherapy boosts breast cancer patients’ quality of life
For many women with breast cancer, the very treatment that saves their lives can also bring fatigue, loss…
Case report examines potential cancer risks after mRNA vaccination
A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the potential link between…
University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Reprogrammed neutrophils promote tumor growth
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
Prevention, Early Detection Could Cut Global Cancer Burden: WHO
Up to four in 10 cancer cases worldwide could be prevented by reducing exposure to known risk factors,…
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States…
Three bottles of vodka? How to cut Aussie cancer deaths by 4%
If Australians cut their alcohol consumption by 1L of pure alcohol a year, deaths from four key cancers…
JPM26: J&J reveals oncology strategy
CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Discovery links human M cells to early steps of celiac disease
The human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types…
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification…